STORY AT-A-GLANCE
For years, Big Pharma has had its eye on mRNA gene transfer technology. In 2019, a Milken Institute panel specifically discussed how they might achieve the transition from conventional vaccine development to novel mRNA technology
A year into the rollout of the COVID jabs, we’re realizing just how lacking scientists’ understanding of thes…



